Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.69 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.69 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.69 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.69 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.68 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.64 |
| ▸ | FAAH | O00519 | 2/20 | 0.63 |
| ▸ | CHRND | Q07001 | 6/20 | 0.61 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.61 |
| ▸ | CHRNG | P07510 | 2/20 | 0.61 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9519035 | 1.00 | CHRNB2 (0.69) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL12324830 | 0.97 | CHRNB2 (0.69) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL16247369 | 0.97 | CHRNB2 (0.69) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL21356921 | 0.96 | CHRNB2 (0.65) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL21356920 | 0.96 | CHRNB2 (0.65) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL4740245 | 0.96 | CHRNB2 (0.65) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL988166 | 0.94 | CHRNB2 (0.77) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL5817448 | 0.93 | FAAH (0.71) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL23086284 | 0.93 | PTPN1 (0.68) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 | |
| SCHEMBL1988507 | 0.92 | CHRNB2 (0.68) | CHRNB2CHRNB4CHRNA3CHRNA4GRIA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021023-A1 | OIL-BASED SOLID COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2026-01-22 | — | — | US | disclosed |
| WO-2025126664-A1 | NONAQUEOUS COMPOSITION FOR ORAL CAVITY | 花王株式会社 | 2025-06-19 | — | — | WO | disclosed |
| US-20050077648-A1 | Solution casting method and polymer film | FUJIFILM CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1094059-B1 | Process for production of N-acyl amino acid amide | AJINOMOTO KK (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6335468-B1 | CONDENSING N-ACYL AMINO ACID OR SALT THEREOF WITH AMINE AND/OR AMMONIA UNDER DEHYDRATING CONDITIONS IN PRESENCE OF BORON COMPOUND AS CATALYST WITH ALCOHOL COEXISTENT AS AUXILIARY SOLVENT | AJINOMOTO CO., INC. (JP) | 2002-01-01 | — | — | US | disclosed |
| EP-1094059-A1 | Process for production of N-acyl amino acid amide | Ajinomoto Co., Inc. (JP) | 2001-04-25 | — | — | EP | disclosed |
| EP-0312624-B1 | PHOTOSENSITIVE COMPOSITION | TORAY INDUSTRIES, INC. (JP) | 1993-07-21 | — | — | EP | disclosed |
| US-5064806-A | CONTAINING AN ALKYLAMMONIUM SALT; HIGH COLOR DENSITY, LOW BACKGROUND STRAIN | MITSUBISHI PAPER MILLS LIMITED (JP) | 1991-11-12 | — | — | US | disclosed |
| US-4927739-A | Photosensitive composition containing a gelling agent | TORAY INDUSTRIES, INC. (JP) | 1990-05-22 | — | — | US | disclosed |
| EP-0312624-A1 | Photosensitive composition | TORAY INDUSTRIES, INC. (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4181527-A | HYDROPHILIC COLLOID | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021023-A1 | OIL-BASED SOLID COSMETIC | CUTA, CHEK1, TYR | CHRNB2 1383/4885CHRNB4 1385/4885CHRNA3 2058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.